J. Courty

M. Tulliez, D. Papy-Garcia, J. Courty, 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy

J. Penelle, E. Giraudo, E. Leroy, 2017, Oncotarget.

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

K. Pogoda, F. Gazeau, R. Bucki, 2020, bioRxiv.

A peptide corresponding to the C‐terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro

E. Papadimitriou, G. Spyroulias, P. Cordopatis, 2011, Journal of cellular biochemistry.

IMMUNOASSAY FOR MEASURING THE HEPARIN-BINDING GROWTH FACTORS HARP AND MK IN BIOLOGICAL FLUIDS

I. Bernard, P. Soulié, P. Milhiet, 2002, Journal of immunoassay & immunochemistry.

Cellular Distribution of the Angiogenic Factor Heparin Affin Regulatory Peptide (HARP) mRNA and Protein in the Human Mammary Gland

J. Sabourin, M. Crépin, J. Courty, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Biochemical and mitogenic properties of the heparin-binding growth factor HARP.

F. Vacherot, J. Courty, D. Barritault, 1995, Progress in growth factor research.

Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.

M. Jaye, F. Vacherot, J. Courty, 1994, Growth factors.

Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.

E. Papadimitriou, J. Courty, M. Héroult, 2000, Biochemical and biophysical research communications.

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options

L. Piemonti, J. Courty, C. Pignatelli, 2021, Cancers.

Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma

M. Boniotto, A. Couvelard, P. Bouvet, 2021, Cancers.

Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co

C. Overall, G. Butler, J. Courty, 2007, Molecular and Cellular Biology.

Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.

E. Papadimitriou, J. Courty, J. Delbe, 2004, The international journal of biochemistry & cell biology.

Heparin affin regulatory peptide in milk: its involvement in mammary gland homeostasis.

I. Bernard-Pierrot, C. Rosty, P. Soulié, 2004, Biochemical and biophysical research communications.

Heparin Affin Regulatory Peptide/Pleiotrophin Mediates Fibroblast Growth Factor 2 Stimulatory Effects on Human Prostate Cancer Cells*

C. Polytarchou, M. Hatziapostolou, E. Papadimitriou, 2006, Journal of Biological Chemistry.

N6L-functionalized nanoparticles for targeted and inhibited pancreatic cancer cells

Tina Modjinou, J. Courty, I. Cascone, 2020 .

Targeting nucleolin for better survival in diffuse large B-cell lymphoma

R. Mathur, L. Sehgal, J. Courty, 2018, Leukemia.

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice

Masashi Kato, J. Briand, A. Prévost-Blondel, 2010, BMC Cancer.

Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option

B. Vallée, J. Courty, J. Cohen, 2021, Nanotechnology.

Nanoparticles Functionalized with Ligands of Cell Surface Nucleolin for Cancer Therapy and Diagnosis

D. Destouches, Maha Sader, J. Courty, 2015 .

Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin.

J. Courty, D. Barritault, M. Perderiset, 1991, Biochemical and biophysical research communications.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

A. van Dorsselaer, J. Beyrath, P. Albanese, 2011, Cancer research.

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

P. Albanese, J. Briand, G. Guichard, 2008, PloS one.

A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ

J. Courty, J. Delbe, Apostolos Polykratis, 2010, Molecular Cancer.

Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor

V. Megalooikonomou, N. Kieffer, E. Papadimitriou, 2015, Molecular Cancer.

Development and testing of radio and enzyme immunoassays for acidic fibroblast growth factor (aFGF).

J. Grassi, J. Courty, D. Barritault, 1988, Analytical biochemistry.

Loss of Receptor Protein Tyrosine Phosphatase β/ζ (RPTPβ/ζ) Promotes Prostate Cancer Metastasis*

J. Courty, Z. Diamantopoulou, P. Katsoris, 2012, The Journal of Biological Chemistry.

Host factor pleiotrophin induces human immunodeficiency virus type 1 replication associated with inflammatory cytokine expression.

J. Courty, A. Achour, J. M'bika, 2010, The Journal of general virology.

Involvement of heparin affin regulatory peptide in human prostate cancer

D. Chopin, F. Vacherot, J. Courty, 1999, The Prostate.

Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation

P. Bouvet, J. Courty, I. Cascone, 2021, Cancers.

Characterization of Heparin Affin Regulatory Peptide Signaling in Human Endothelial Cells*

E. Papadimitriou, J. Courty, Apostolos Polykratis, 2005, Journal of Biological Chemistry.

Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients.

I. Bernard-Pierrot, P. Soulié, J. Courty, 2004, Cancer detection and prevention.

The Lysine-rich C-terminal Tail of Heparin Affin Regulatory Peptide Is Required for Mitogenic and Tumor Formation Activities*

I. Bernard-Pierrot, P. Milhiet, J. Courty, 2001, The Journal of Biological Chemistry.

Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells.

E. Papadimitriou, J. Courty, Constantinos M Mikelis, 2006, In vivo.

Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

C. Casari, C. Denis, M. Pâques, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Presence of basic fibroblast growth factor receptors in bovine brain membranes.

A. Méreau, J. Courty, D. Barritault, 1988, The Journal of biological chemistry.

Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse

H. Hondermarck, J. Courty, D. Thomas, 1990, Experientia.

Adult Brain but Not Kidney, Liver, Lung, Intestine, and Stomach Membrane Preparations Contain Detectable Amounts of High‐Affinity Receptors to Acidic and Basic Growth Factors a

M. Jaye, A. Méreau, J. Courty, 1991, Annals of the New York Academy of Sciences.

The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt.

Rodolfo Miranda, I. Hilger, A. Prina‐Mello, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.

A. Weber, J. Courty, S. Belbekhouche, 2020, ACS applied materials & interfaces.

Pleiotrophin inhibits HIV infection by binding the cell surface‐expressed nucleolin

J. Courty, J. Delbe, E. Said, 2005, The FEBS journal.

[Effects of the growth factors EDGF I and EDGF II on wound healing of the corneal epithelium in rabbits].

Y. Courtois, J. Courty, Y. Pouliquen, 1987, Comptes rendus des seances de la Societe de biologie et de ses filiales.

Soluble heparin-binding lectins from human brain: purification, specificity and relationship to an heparin-binding growth factor.

M. Caron, J. Courty, D. Bladier, 1990, The International journal of biochemistry.

Priority paper Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway

M. Crépin, T. Issad, J. Courty, 1998 .

Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2

G. Carpentier, M. Amiche, J. Courty, 2012, PloS one.

Dermaseptin b2 as an inhibitor of tumor growth

A. Ladram, P. Nicolas, M. Amiche, 2009 .

Antitumor and angiostatic peptides from frog skin secretions

A. Ladram, P. Nicolas, M. Amiche, 2010, Amino Acids.

Evidence for Novel Action at the Cell‐Binding Site of Human Angiogenin Revealed by Heteronuclear NMR Spectroscopy, in silico and in vivo Studies

D. Leonidas, J. Hayes, G. Spyroulias, 2018, ChemMedChem.

Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery

M. Calero, Rodolfo Miranda, Á. Villanueva, 2015, Breast Cancer Research.

Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies

M. Pâques, J. Courty, I. Cascone, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Upregulation of heparin-affin regulatory peptide by androgen

F. Vacherot, J. Courty, D. Barritault, 1995, In Vitro Cellular & Developmental Biology - Animal.

Pleiotrophin promotes capillary-like sprouting from senescent aortic rings.

J. Courty, J. Delbe, S. Besse, 2013, Cytokine.

Glycosaminoglycans promote HARP/PTN dimerization.

I. Bernard-Pierrot, P. Milhiet, J. Courty, 1999, Biochemical and biophysical research communications.

Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal interneurons

M. Murer, O. Gershanik, R. Raisman‐Vozari, 2005, Brain Research.

Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats

M. Murer, O. Gershanik, F. Pitossi, 2011, Molecular Neurodegeneration.

Dynamic mesenchymal stem cells volumic seeding in a commercialized porous ceramic scaffold: a feasibility study

S. Naili, T. Lemaire, P. Albanese, 2014, Computer methods in biomechanics and biomedical engineering.

Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson’s disease

L. Lanfumey, M. Hamon, A. S. Aguiar, 2011, Journal of Neural Transmission.

Functionalization of Iron Oxide Magnetic Nanoparticles with the Multivalent Pseudopeptide N6l for Breast Tumor Targeting

Alex, G. Carpentier, A. Cortajarena, 2015 .

P 363 Heparin affin regulatory peptide (HARP) in human ocular tissues

A. Gaudric, M. Pâques, F. Vacherot, 1995, Vision Research.

Exogenous Pleiotrophin Applied to Lesioned Nerve Impairs Muscle Reinnervation

A. Ferry, G. Carpentier, J. Courty, 2006, Neurochemical Research.

Cell Colonization Ability of a Commercialized Large Porous Alveolar Scaffold

S. Naili, T. Lemaire, P. Albanese, 2017, Applied bionics and biomechanics.

Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release*

G. Carpentier, J. Briand, Maha Sader, 2012, The Journal of Biological Chemistry.

Loss of Receptor Protein Tyrosine Phosphatase β/ζ (RPTPβ/ζ) Promotes Prostate Cancer Metastasis*

J. Courty, Z. Diamantopoulou, P. Katsoris, 2012, The Journal of Biological Chemistry.

A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis*

J. Courty, D. Barritault, E. Petit, 2005, Journal of Biological Chemistry.

Modulation of Inflammation by Cicaderma Ointment Accelerates Skin Wound Healing

G. Carpentier, A. Roumegous, J. Courty, 2012, Journal of Pharmacology and Experimental Therapeutics.

Identification of Heparin-binding Sites in Proteins by Selective Labeling*

A. Ori, D. Fernig, J. Courty, 2009, Molecular & Cellular Proteomics.

Isolation of Basic FGF Receptors from Adult Bovine Brain Membranes a

A. Méreau, J. Courty, D. Barritault, 1991, Annals of the New York Academy of Sciences.

Use of Eye Derived Growth Factor from Retina (EDGF) in a Defined Medium for the Culture of Bovine Epithelial Lens Cells

Y. Courtois, J. Courty, D. Barritault, 1983 .